Indian pharmaceutical companies, long celebrated as the “pharmacy of the world” for their affordable generic medicines, are now charting a strategic course toward specialty drugs, biosimilars, and innovative therapies. This…
🇺🇸 US Imposes 100% Tariff on Patented Drug Imports from India In a major trade policy shift, the United States imposed a 100% tariff on patented pharmaceutical products imported from…
Indian generic drugmakers have launched a wave of affordable semaglutide products following the expiry of Novo Nordisk's key patents, with over 50 brands expected in the coming months and prices…
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is implementing one of the most ambitious regulatory overhauls in its history. In a series of coordinated actions between February…